CORD-19:c654596857bce9cdd64ffc51842048643107348c / 118077-118417 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T997","span":{"begin":0,"end":340},"obj":"Sentence"},{"id":"T56897","span":{"begin":0,"end":340},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Susceptibility testing (semiautomated broth microdilution method, Sensititre, Trek Diagnostics, USA, following NCCLS recommendations) was performed with six different quinolones to 817 Streptococcus pneumoniae isolates with a ciprofloxacin-CIP */MIC ]/2 mg/l collected in two consecutive SAUCE$ surveillances in Spain (1996 Á/97/1998 Á/99)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T180","span":{"begin":0,"end":340},"obj":"Sentence"}],"text":"Susceptibility testing (semiautomated broth microdilution method, Sensititre, Trek Diagnostics, USA, following NCCLS recommendations) was performed with six different quinolones to 817 Streptococcus pneumoniae isolates with a ciprofloxacin-CIP */MIC ]/2 mg/l collected in two consecutive SAUCE$ surveillances in Spain (1996 Á/97/1998 Á/99)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T154","span":{"begin":199,"end":209},"obj":"Phenotype"}],"attributes":[{"id":"A154","pred":"hp_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Susceptibility testing (semiautomated broth microdilution method, Sensititre, Trek Diagnostics, USA, following NCCLS recommendations) was performed with six different quinolones to 817 Streptococcus pneumoniae isolates with a ciprofloxacin-CIP */MIC ]/2 mg/l collected in two consecutive SAUCE$ surveillances in Spain (1996 Á/97/1998 Á/99)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T481","span":{"begin":185,"end":209},"obj":"Disease"},{"id":"T482","span":{"begin":240,"end":243},"obj":"Disease"},{"id":"T79980","span":{"begin":185,"end":209},"obj":"Disease"},{"id":"T13530","span":{"begin":240,"end":243},"obj":"Disease"}],"attributes":[{"id":"A481","pred":"mondo_id","subj":"T481","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A482","pred":"mondo_id","subj":"T482","obj":"http://purl.obolibrary.org/obo/MONDO_0009459"},{"id":"A483","pred":"mondo_id","subj":"T482","obj":"http://purl.obolibrary.org/obo/MONDO_0015364"},{"id":"A82441","pred":"mondo_id","subj":"T79980","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A19991","pred":"mondo_id","subj":"T13530","obj":"http://purl.obolibrary.org/obo/MONDO_0009459"},{"id":"A46001","pred":"mondo_id","subj":"T13530","obj":"http://purl.obolibrary.org/obo/MONDO_0015364"}],"text":"Susceptibility testing (semiautomated broth microdilution method, Sensititre, Trek Diagnostics, USA, following NCCLS recommendations) was performed with six different quinolones to 817 Streptococcus pneumoniae isolates with a ciprofloxacin-CIP */MIC ]/2 mg/l collected in two consecutive SAUCE$ surveillances in Spain (1996 Á/97/1998 Á/99)."}